Do you want to read an article? Please log in or register.
Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial
Allergic DiseasesImmunotherapy